{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:38:34Z","timestamp":1762954714282},"reference-count":29,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T00:00:00Z","timestamp":1193270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Bullous pemphigoid (BP) usually responds well to conventional therapies, although some severe cases show less response to various therapies or develop side\u2010effects due to long\u2010term drug administration using high doses. Most BP patients are elderly and are thus prone to systemic deterioration or unfavorable outcome. In the present study, we investigated the efficacy of interferon\u2010\u03b3 on severe BP patients resistant to conventional therapies. Interferon\u2010\u03b3 was administered to 10 severe BP patients at a dose of 2\u00a0million Japan reference units (JRU) once a day for 7 consecutive days by i.v. infusion in addition to oral corticosteroids. The degree of improvement in the clinical symptoms, serum interleukin (IL)\u20104, IL\u20105, and plasma RANTES concentrations, as well as the results of indirect immunofluorescence and BP180 enzyme\u2010linked immunosorbent assay index values, were compared before and after the 7\u2010day drug administration. Among the nine patients whose clinical symptoms were evaluated, an improvement was observed in all patients. Except for one patient, the serum IL\u20104 concentrations decreased and similar results were observed for the serum IL\u20105 concentration. All five patients in whom the plasma RANTES concentration was measured showed decreased levels. The indirect immunofluorescence titers decreased in only four patients. However, in seven patients in whom index values of BP180 enzyme\u2010linked immunosorbent assay were evaluated, all patients showed significant decrease of the index values. These results suggest that, in severe BP patients refractory to conventional therapies, interferon\u2010\u03b3 in addition to oral corticosteroids is effective and thus should be considered for further clinical use.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2007.00375.x","type":"journal-article","created":{"date-parts":[[2007,10,27]],"date-time":"2007-10-27T19:16:23Z","timestamp":1193512583000},"page":"737-745","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of interferon\u2010\u03b3 in patients with refractory bullous pemphigoid"],"prefix":"10.1111","volume":"34","author":[{"given":"Takekuni","family":"NAKAMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norito","family":"ISHII","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitake","family":"ONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"HAMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"YASUMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"HASHIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,10,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70061-7"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04835.x"},{"key":"e_1_2_6_4_2","first-page":"427","article-title":"Eleven cases of bullous pemphigoid treated with combination of minocycline and nicotinamide","volume":"6","author":"Kawahara Y","year":"1996","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02498.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1960.tb13838.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archderm.1978.01640230013003","article-title":"Bullous pemphigoid","volume":"114","author":"Downham TF","year":"1978","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690060083010"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70336-0"},{"key":"e_1_2_6_10_2","first-page":"231","article-title":"Immunohistochemical evaluation of eosinophil using mouse anti\u2010human ECP monoclonal antibody (EG2)","volume":"150","author":"Nakama T","year":"1989","journal-title":"J Clin Exp Med (IGAKU NO AYUMI)"},{"key":"e_1_2_6_11_2","unstructured":"NakamaT TsudaS.Ultrastructural and immunocytochemical aspects of infiltrated eosinophils in bullous pemphigoid. Electron Microscopy in Dermatology.Basic and Clinical Researchedited byISHIBASHIet\u00a0al. Excerpta Medica1994:181\u2013185."},{"key":"e_1_2_6_12_2","first-page":"310","article-title":"Bullous pemphigoid: cytotoxic eosinophil degranulation and release of eosinophil major basic protein","volume":"76","author":"Wintroub BU","year":"1981","journal-title":"J Invest Dermatol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12505711"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4049\/jimmunol.116.1.112","article-title":"An eosinophilic chemotactic factor present in blister fluid of bullous pemphigoid","volume":"116","author":"Baba T","year":"1976","journal-title":"J Immunol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12581617"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00412972"},{"key":"e_1_2_6_17_2","first-page":"59","volume-title":"Allergic dermatosis \u201cBasic and Clinical Aspect\u201d","author":"Tsuda S","year":"1989"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1992.tb03224.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050259"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3335"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02907.x"},{"key":"e_1_2_6_22_2","first-page":"27","article-title":"Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid","volume":"12","author":"Frezzolini A","year":"2002","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60503-9"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117826"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119639"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","article-title":"Bullous pemphigoid and herpes gestationic autoantibodies recognize a common non\u2010collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice GJ","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02505245","article-title":"The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180\u00a0KDa bullous pemphigoid antigen","volume":"288","author":"Matsumura K","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12338088"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.2.174"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(00)00149-3"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2007.00375.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2007.00375.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T15:58:10Z","timestamp":1697212690000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2007.00375.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,25]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1346-8138.2007.00375.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2007.00375.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,25]]}}}